Bernstein trims AstraZeneca target price
Bernstein cut its target price on AstraZeneca to 198 pounds from 200 pounds while reiterating a constructive long-term view on the drugmaker's pipeline. AstraZeneca shares rose 1% to 120.80 pounds.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
5 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Bernstein trims AstraZeneca target to 198 pounds
Bernstein cut its price target on AstraZeneca to 198 pounds from 200 pounds and kept a positive view on the drugmaker's long-term outlook. Shares in AstraZeneca were up 1% at 120.80 pounds.
Top Glove Earnings Expected to Trend Lower, Analyst Says
CIMB Securities analyst Chun Sung Oong noted that Top Glove's earnings have likely peaked and could trend lower toward normalized levels in the coming quarters. While glove prices could remain elevated, they have eased from their June peak, with higher labor costs contributing to the trend.
Global Equities Roundup: Market Talk
The latest Market Talks covering Equities. Published exclusively on Dow Jones Newswires throughout the day. 0204 GMT - Malaysia's Budget 2027 is expected to offer policy support to favor domestic manufacturing and strengthen the automotive supply chain, says Affin Hwang IB analyst Afifah Ishak in a note. This should be
Full Transcript: Leidos Holdings Q2 2026 Earnings Call
Leidos Holdings (NYSE: LDOS ) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Lei